High-risk prostate cancer: is androgen deprivation monotherapy still appropriate?

被引：0
|
作者：
Shahinian, Vahakn B. [1 ]
机构：
[1] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA
来源：
ASIAN JOURNAL OF ANDROLOGY | 2012年 / 14卷 / 03期
关键词：
EXTERNAL-BEAM RADIOTHERAPY; RADIATION-THERAPY; TRIAL; SUPPRESSION;
D O I：
10.1038/aja.2011.182
中图分类号：
R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
摘要：
引用
收藏
页码：419 / 420
页数：2
相关论文
共 50 条
  • [1] Androgen Deprivation Therapy in High-Risk Prostate Cancer
    Buyyounouski, Mark K.
    [J]. ONCOLOGY-NEW YORK, 2010, 24 (09): : 806 - 809
  • [2] What is appropriate neoadjuvant/adjuvant androgen deprivation for high-risk/locally advanced prostate cancer?
    Namiki, Mikio
    Konaka, Hiroyuki
    [J]. ASIAN JOURNAL OF ANDROLOGY, 2011, 13 (04) : 624 - 625
  • [3] Androgen Deprivation Therapy in High-Risk Localized and Locally Advanced Prostate Cancer
    Iwamoto, Hiroaki
    Izumi, Kouji
    Makino, Tomoyuki
    Mizokami, Atsushi
    [J]. CANCERS, 2022, 14 (07)
  • [4] Eighteen Months of Androgen Deprivation Therapy in Men with High-risk Prostate Cancer and the Risk of Death
    Xie, Wanling
    D'Amico, Anthony V.
    [J]. EUROPEAN UROLOGY, 2018, 74 (04) : 442 - 443
  • [5] Androgen deprivation therapy in high risk prostate cancer
    Van Dams, Ritchell
    Kishan, Amar U.
    [J]. TRANSLATIONAL CANCER RESEARCH, 2019, 8 (05) : 2216 - 2217
  • [6] Duration of androgen deprivation therapy in high-risk prostate cancer: A randomized trial.
    Nabid, Abdenour
    Carrier, Nathalie
    Martin, Andre-Guy
    Bahary, Jean-Paul
    Souhami, Luis
    Duclos, Marie
    Vincent, Francois
    Vass, Sylvie
    Bahoric, Boris
    Archambault, Robert
    Lemaire, Celine
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (18)
  • [7] Androgen Deprivation Therapy: A Survival Benefit or Detriment in Men With High-Risk Prostate Cancer?
    Fang, L. Christine
    Merrick, Gregory S.
    Wallner, Kent E.
    [J]. ONCOLOGY-NEW YORK, 2010, 24 (09): : 790 - 797
  • [8] Influences on androgen deprivation therapy prescribing before surgery in high-risk prostate cancer
    Dunsmore, Jennifer
    Duncan, Eilidh
    Maclennan, Sara J.
    N'Dow, James
    Cornford, Philip
    Esperto, Francesco
    Pavan, Nicola
    Ribal, Maria J.
    Roobol, Monique J.
    Skolarus, Ted A.
    Maclennan, Steven
    [J]. BJUI COMPASS, 2024, 5 (09): : 874 - 884
  • [9] Duration of androgen deprivation therapy in high-risk prostate cancer: A randomized trial.
    Nabid, Abdenour
    Carrier, Nathalie
    Martin, Andre-Guy
    Bahary, Jean-Paul
    Souhami, Luis
    Duclos, Marie
    Vincent, Francois
    Vass, Sylvie
    Bahoric, Boris
    Archambault, Robert
    Lemaire, Celine
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [10] Androgen deprivation therapy in combination with radiotherapy for high-risk clinically localized prostate cancer
    Nishiyama, Tsutomu
    [J]. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2012, 129 (3-5): : 179 - 190
12345